Drug Interaction Report

Colchicine and Lanreotide: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Colchicine

Colcrys Colcrys® Gloperba Gloperba® Lodoco Mitigare
+

Lanreotide

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 223 documented Colchicine interactions, 107 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Lanreotide may slow the breakdown of colchicine and raise the risk of colchicine side effects, so your care team may avoid the combination or lower your colchicine dose and monitor you more closely. Do not change anything on your own; check with your pharmacist or doctor.

Colchicine is used for gout and some inflammatory conditions, and it is broken down by a liver enzyme called CYP3A4. Lanreotide may slow that enzyme down a bit by lowering growth hormone. In theory, that means colchicine could build up in your body and cause more side effects, like stomach upset, diarrhea, or muscle problems.

I want to be honest: this concern is theoretical, meaning it is based on how the drugs work rather than lots of real-world reports. Colchicine also has a narrow safe range, so even small changes matter. The good news is your care team can manage this easily by watching you closely and adjusting your dose if needed. Please talk with your pharmacist or doctor before changing anything.

Mechanism: Lanreotide (a somatostatin analog) may inhibit CYP3A4 secondary to growth hormone suppression. Colchicine is a CYP3A4 (and P-gp) substrate with a narrow therapeutic index, so reduced metabolism could increase colchicine exposure (AUC/Cmax).

  • Direction: increased colchicine effect and toxicity risk (GI, myotoxicity, neuromyopathy, marrow suppression).
  • Evidence: theoretical; magnitude not quantified.
  • Onset: unspecified.
  • Management: avoid combining lanreotide with a low-TI CYP3A4 substrate where possible. If co-administration is required, consider colchicine dose reduction and monitor for toxicity, especially with hepatic or renal impairment.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Altered exposure to CYP3A4 substrate

Interaction Deep Dive

Because they suppress growth hormone, somatostatin analogs like lanreotide may indirectly inhibit CYP enzymes. As a result, the plasma levels of a CYP3A4 substrate could be altered. Do not use lanreotide together with a CYP3A4 substrate that has a narrow therapeutic index. When lanreotide must be given alongside a drug that undergoes primarily hepatic metabolism, a dosage adjustment of the substrate should be considered1.

Why it happens (mechanism)

Inhibition of metabolism of CYP3A4 substrate secondary to lanreotide suppression of growth hormone

How to manage this interaction

Keep taking both medications exactly as prescribed unless your care team tells you otherwise. Because colchicine has a narrow safe range, your team pays extra attention here.

  • Your prescriber may prefer to avoid using these two together when possible.
  • If both are needed, your colchicine dose may be adjusted and individualized, and your team may monitor you more closely.
  • Watch for and report signs of too much colchicine, such as diarrhea, nausea, vomiting, unusual muscle pain or weakness, numbness, or tingling.
  • Tell your pharmacist and doctor about all your medications, and about any kidney or liver problems.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Colchicine and Lanreotide together?

Lanreotide may slow the breakdown of colchicine and raise the risk of colchicine side effects, so your care team may avoid the combination or lower your colchicine dose and monitor you more closely. Do not change anything on your own; check with your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Colchicine and Lanreotide interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Colchicine and Lanreotide interaction managed?

Keep taking both medications exactly as prescribed unless your care team tells you otherwise. Because colchicine has a narrow safe range, your team pays extra attention here. Your prescriber may prefer to avoid using these two together when possible. If both are needed, your colchicine dose may be adjusted and individualized, and your team may monitor you more closely. Watch for and report signs o… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Colchicine or Lanreotide need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: SOMATULINE(R) DEPOT subcutaneous injection, lanreotide subcutaneous injection. Ipsen Biopharmaceuticals Inc (per manufacturer), Basking Ridge, NJ, 2017. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.